Lv4
750 积分 2024-02-02 加入
CAR-T-Cell Therapy Based on Immune Checkpoint Modulation in the Treatment of Hematologic Malignancies
4小时前
已关闭
Newer generations of multi-target CAR and STAb-T immunotherapeutics: NEXT CART Consortium as a cooperative effort to overcome current limitations
15小时前
已完结
In vivo gene editing and in situ generation of chimeric antigen receptor cells for next-generation cancer immunotherapy
15小时前
已完结
CAR-T cell manufacturing: Major process parameters and next-generation strategies
15小时前
已完结
Deciphering the tumor immune microenvironment from a multidimensional omics perspective: insight into next-generation CAR-T cell immunotherapy and beyond
15小时前
已完结
Circulating tumor DNA (ctDNA)—the next generation biomarker in non-small cell lung cancer patients treated with immunotherapy?
15小时前
已关闭
Phage display based biosensing: Recent advances and challenges
27天前
已完结
Protocol for High Throughput Screening of Antibody Phage Libraries
27天前
已完结
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
1个月前
已完结
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept
1个月前
已完结
皖公网安备34019202002308
